Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Dyslipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01551173
What this trial is testing

Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Lipid Metabolism Disorders
Novartis Pharmaceuticals 436
Early research (Phase 1)Looking for participantsNCT06932705
What this trial is testing

Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

Who this might be right for
Mixed Dyslipidemia
Addpharma Inc. 48
Not applicableEnded earlyNCT01228019
What this trial is testing

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,166
Early research (Phase 1)Looking for participantsNCT07491172
What this trial is testing

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Who this might be right for
CardiovascularMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG 90
Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT04998201
What this trial is testing

Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemia
Arrowhead Pharmaceuticals 353
Testing effectiveness (Phase 2)Study completedNCT07278830
What this trial is testing

A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hypercholesterolemia and Mixed Dyslipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 214
Post-approval studies (Phase 4)WithdrawnNCT02069106
What this trial is testing

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

Who this might be right for
Mixed Hyperlipoproteinemia
Nordic Pharma, USA
Large-scale testing (Phase 3)WithdrawnNCT02947334
What this trial is testing

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Who this might be right for
Primary Hyperlipidemia or Mixed Dyslipidemia
Pfizer
Not applicableStudy completedNCT02730559
What this trial is testing

Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial

Who this might be right for
Dyslipidemias
The Hospital for Sick Children 32
Large-scale testing (Phase 3)Study completedNCT00269204
What this trial is testing

Lipid Efficacy/Tolerability Study (0524A-020)

Who this might be right for
Primary HypercholesterolaemiaMixed Hyperlipidaemia
Merck Sharp & Dohme LLC 1,620
Large-scale testing (Phase 3)Not Yet RecruitingNCT07444086
What this trial is testing

QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 510
Large-scale testing (Phase 3)Study completedNCT02189837
What this trial is testing

Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody

Who this might be right for
Primary Hyperlipidemia and Mixed Dyslipidemia
Amgen 89
Large-scale testing (Phase 3)Study completedNCT02548832
What this trial is testing

Bezafibrate Plus Berberine in Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemia
University of Guadalajara 36
Early research (Phase 1)Study completedNCT07495514
What this trial is testing

Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers

Who this might be right for
Mixed DyslipidemiaFood Effect Study of AD-117
Addpharma Inc. 60
Post-approval studies (Phase 4)UnknownNCT01010516
What this trial is testing

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia

Who this might be right for
Dyslipidemia
University of Ioannina 120
Early research (Phase 1)Study completedNCT01632358
What this trial is testing

Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients

Who this might be right for
Dyslipidaemia
Novartis Pharmaceuticals 279
Not applicableActive Not RecruitingNCT05399992
What this trial is testing

Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 847
Large-scale testing (Phase 3)Study completedNCT01854918
What this trial is testing

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemia and Mixed Dyslipidemia
Amgen 3,681
Large-scale testing (Phase 3)Study completedNCT00349375
What this trial is testing

Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

Who this might be right for
Hyperlipidemia
Solvay Pharmaceuticals 1,040
Next Page